Small-Molecule Drugs
Omeprazole
Last reviewed: 2026-11-19
Evidence status & limitations
Controlled studies support specific acid-related indications; the evidence does not support unrelated general-health claims.
Regulatory status
FDA approval applies only to the named products and indications below. It does not approve every formulation or other use.
Prilosec · Acid-related Disorders
Specified ulcers, reflux-related disease and pathological hypersecretory conditions; populations and combination regimens are label-specific.
Authoritative label record
Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.
WADA prohibited status: current list and contextKnown risks & open questions
Drug interactions and selected infection, electrolyte and long-term exposure concerns are documented.
Key sources
Indication-specific regulatory sources and editorial screen checked November 19, 2026. This is not an exhaustive systematic review; consult current labels.
Related compounds
- Apomorphine
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Finasteride
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Metformin
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Methylthioninium chloride
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Minoxidil
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications